Current stage -Stage II Posts on Medivizor
Navigation Menu

Current stage -Stage II Posts on Medivizor

Are radiotherapy and surgery equally good at treating localized prostate cancer?

Are radiotherapy and surgery equally good at treating localized prostate cancer?

Posted by on Sep 26, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared surgery and radiotherapy for treating localized prostate cancer. They found no significant difference in survival between the two treatments. Some background Localized prostate cancer (cancer which has not spread beyond the prostate gland) can be treated with either surgery, radiotherapy, or monitoring without...

Read More

Comparing the effectiveness of apalutamide, darolutamide and enzalutamide in treating nonmetastatic castration-resistant prostate cancer

Comparing the effectiveness of apalutamide, darolutamide and enzalutamide in treating nonmetastatic castration-resistant prostate cancer

Posted by on Jul 26, 2020 in Prostate cancer | 0 comments

In a nutshell The study compared outcomes of apalutamide (A; Erleada), darolutamide (D; Nubeqa), and enzalutamide (E; Xtandi) in treating nonmetastatic castration-resistant prostate cancer (nmCRPC). The authors found that A and E had better metastasis-free survival (MFS) compared to D. Some background Men with CRPC fail to respond to...

Read More

Evaluating the risk of secondary cancers after internal radiation therapy in patients with prostate cancer

Evaluating the risk of secondary cancers after internal radiation therapy in patients with prostate cancer

Posted by on Jun 25, 2020 in Prostate cancer | 0 comments

In a nutshell This study looked at the long-term risk of secondary cancers following brachytherapy (BT; internal radiation therapy) for prostate cancer. It found that treating prostate cancer with BT had a low risk of secondary cancers. Some background Prostate cancer is a slow-growing cancer of the prostate gland. Men with prostate cancer that has...

Read More

Does enzalutmide improve survival in nonmetastatic, castration-resistant prostate cancer?

Does enzalutmide improve survival in nonmetastatic, castration-resistant prostate cancer?

Posted by on Jun 21, 2020 in Prostate cancer | 0 comments

In a nutshell The study assessed whether enzalutamide (Xtandi) plus androgen deprivation therapy (ADT) increased overall survival (OS) of patients with nonmetastatic, castration-resistant prostate cancer (CRPC). The study found improved survival in patients with CRPC treated with enzalutamide. Some background ADT is a type of hormonal therapy...

Read More

Should androgen-deprivation therapy be given at the same time or before radiotherapy in the treatment of localized prostate cancer?

Should androgen-deprivation therapy be given at the same time or before radiotherapy in the treatment of localized prostate cancer?

Posted by on Jun 11, 2020 in Prostate cancer | 0 comments

In a nutshell The study looked at the sequence of dose-escalated radiotherapy (RT) and androgen-deprivation therapy (ADT) in the treatment of local prostate cancer (LPCa). The study found that treatment with ADT before RT had the same outcome as treatment with ADT and RT at the same time.  Some background LPCa is a form of cancer that is...

Read More

Comparing cryosurgery and hormonal therapy for locally recurrent prostate cancer after radiotherapy

Comparing cryosurgery and hormonal therapy for locally recurrent prostate cancer after radiotherapy

Posted by on Jun 4, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared local cryosurgery (CRYO) against androgen deprivation therapy (ADT) for the treatment of locally recurring prostate cancer (LRPC). The study found local cryosurgery had a longer overall survival (OS) when compared to ADT. Some background LRPC is cancer that has re-occurred in the prostate gland...

Read More

Focal high-intensity focussed ultrasound for the treatment of localized prostate cancer

Posted by on Oct 5, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the use of high-intensity focal ultrasound (HIFU) for the treatment of localized prostate cancer. This study found that HIFU is a safe treatment with good oncological results and minimal side-effects.  Some background High-intensity focused ultrasound (HIFU) is a non-invasive technique that uses...

Read More

Outcomes and side-effects after prostate surgery and intensity modulated radiation therapy

Posted by on Jul 21, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate long-term outcomes of radiation therapy after prostate surgery for prostate cancer. This study found that this is a safe treatment option for these patients. Some background Prostate surgery is a common treatment for prostate cancer (PCa). Intensity-modulated radiation therapy (IMRT) is another option....

Read More

Evaluating image-guided irreversible electroporation of localized prostate cancer

Posted by on Jul 9, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the use of irreversible electroporation (IRE) in the treatment of prostate cancer. This study found that IRE had low side-effect rates and promising outcomes.  Some background Irreversible electroporation (IRE) uses high-energy pulses of electricity to destroy cancer cells. The brand name for...

Read More

What is the risk for bladder and rectal cancer in patients previously treated for localized prostate cancer?

Posted by on Jun 30, 2019 in Prostate cancer | 0 comments

In a nutshell This study investigated the rate of bladder cancer (BC) and rectal cancer (RC) after localized prostate cancer (PC) treatment. They found that brachytherapy (BT) increased the risk of BC and RC in these patients.  Some background Prostate cancer (PC) is a common cancer in men. There are many treatment options for PC. Some involve...

Read More